Financial Performance - Net loss from continued operations for FY2024 was 167.32million,comparedto43.84 million in FY2023 and 75.42millioninFY2022,indicatingasignificantincreaseinlosses[1033].−AdjustedEBITDAlossfromcontinuingoperationsimprovedto30.40 million in FY2024 from 34.82millioninFY2023,and41.36 million in FY2022, showing a positive trend [1033]. - The Company reported a foreign exchange loss of 399,827inFY2024,comparedtoagainof224,057 in FY2023 and a loss of 2.75millioninFY2022,highlightingvolatilityincurrencyimpacts[1033].FinancingandCapitalStructure−TheCompanyamendeditsBridgeFinancing,extendingthematuritytoDecember13,2024,contingentuponreceivingthefirstinstallmentoftheTIPre−paidRoyaltyFee[1041].−TheDesjardinsCreditFacilitywasamendedtoalignwiththeBridgeFacility,withanestimatedrepaymentofapproximately7.1 million due upon completion of the Equity Financing [1042]. - The Company granted a hypothec of 60millionoveritsmovableassetstoDesjardinsaspartofitsfinancingarrangements[1044].−ThecompanyhasissuedatotalofUS2.8 million in Bridge Financing, composed of US0.9millioninNon−ConvertibleandUS1.9 million in Convertible Bridge Loans [1069]. - The company raised approximately US9.0millionfromtheissuanceof5,490,000CommonSharesundertheSEPA[1052].−Thecompanyissued5,490,000commonsharesundertheSEPAagreement,generatingnetproceedsofUS9.0 million [1100]. Internal Controls and Compliance - The Company identified material weaknesses in internal controls over financial reporting, which could affect the accuracy of financial statements [1033]. - The company has identified material weaknesses in its internal controls over financial reporting and is implementing a remediation plan [1064]. - The company has remediated its material weaknesses in internal control over financial reporting as of September 30, 2024 [1095]. - The company has implemented control activities to prevent or detect material misstatements, enhancing its control environment [1095]. - The company has committed to filing annual reports with the SEC, ensuring compliance with U.S. GAAP and other regulatory requirements [1037]. - The company qualifies as a "foreign private issuer" under SEC rules, allowing it to follow Canadian corporate governance practices [1065]. Strategic Collaborations - A strategic collaboration agreement was established with Texas Instruments to develop an integrated platform solution for ADAS and AD markets, with advanced royalty payments to support commercialization [1039]. - The company entered into collaboration and license agreements with Texas Instruments, which includes advanced royalty payments [1069]. Operational Developments - The Company is evaluating alternative ERP systems to better fit its long-term needs following upgrades to its current system [1036]. - The company started using new non-IFRS financial measures in Q2-2024 to better reflect ongoing operating results [1059]. - The company plans to attract and retain qualified directors, executive officers, employees, and consultants through its Omnibus Incentive Plan [1092]. - The company is focused on achieving corporate goals and rewarding exceptional performance through annual equity grants for executive officers [1091]. Future Projections and Risks - The company will remain an emerging growth company until it meets certain revenue or debt thresholds, including achieving total annual gross revenue of US1.07billionormore[1058].−Thecompanyhasidentifiedrisksrelatedtoitsbusinessandtheneedtoraisesubstantialamountsofadditionalcapitaltoaddressliquidityneeds[1100].−Thecompanyisexposedtointerestrateriskprimarilyrelatedtoitslong−termdebtobligationswithfloatinginterestrates[1055].PaymentsandRoyalties−ThecompanyreceivedaninitialpaymentofUS5.0 million on December 12, 2024, as part of a total payment of approximately US10millioninadvanceroyalties[1097].−AsubsequentpaymentofUS3.0 million will follow the completion of the demonstrator, which is planned to debut at the Consumer Electronics Show in Las Vegas next month [1097]. - The final US$1.9 million of the advance royalties is contingent upon the execution of a client contract with an original equipment manufacturer (OEM) [1097].